Key result
IV nitroglycerin linked to increased subendocardial myocardial blood flow in ~79% of LV segments.
Why the study?
It is controversial whether nitroglycerin increases subendocardial myocardial blood flow and whether arterial or venous flow is increased in coronary artery disease patients.
Does intravenous nitroglycerin increase subendocardial myocardial blood flow in patients with coronary artery disease?
Observational (n=58)
Yes
Does intravenous nitroglycerin increase subendocardial myocardial blood flow in patients with coronary artery disease?
Intravenous nitroglycerin increases either arterial or venous subendocardial myocardial blood flow depending on baseline ischemia and fibrosis in patients with coronary artery disease.
It is controversial as to whether or not nitroglycerin (NTG) increases subendocardial myocardial blood flow (SMBF), and if it does, whether arterial or venous blood flow is increased in patients with coronary artery disease. This study was performed to examine NTG-induced changes in SMBF.Changes in SMBF induced by NTG (200 µg, i.v.) were examined by cardioscopy in 58 left ventricular wall segments of 58 patients with coronary artery disease. NTG-induced red and purple endocardial colors were defined as increased arterial and venous SMBF, respectively. Endocardial color before NTG administration was classified into brown, light brown, pale and white. Endomyocardial biopsy of the observed portion and (201)Tl scintigraphy were performed in 40 of these patients immediately after cardioscopy and several days after cardioscopy, respectively.Upon administration of NTG, SMBF increased in 48 of 58 wall segments; arterial SMBF in 34 and venous SMBF in 12 wall segments; arterial SMBF in all 24 brown to light brown segments; venous SMBF, arterial SMBF and no change in 12, 10 and 5 of pale segments, respectively; and no change in all 10 white wall segments. (201)Tl-scintigraphy and endomyocardial biopsy revealed that brown, light brown, pale and white endocardial color represented no ischemia, mild ischemia, severe ischemia and fibrosis, respectively.NTG caused an increase in either arterial or venous SMBF depending on control endocardial color, wall motion and severity of coronary stenosis.
No takes yet. Share an insight, caveat, or question.
Uchida et al. (2011) conducted an observational in Coronary artery disease (n=58). Nitroglycerin vs. Baseline was evaluated on Increase in subendocardial myocardial blood flow (SMBF). Intravenous nitroglycerin increased subendocardial myocardial blood flow in 79% of observed left ventricular wall segments, with arterial or venous flow increases depending on baseline ischemia severity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: